Alternatively, a recent study demonstrated that cancer-derived IgG promotes cervical cancer cell proliferation by enhancing pro-inflammatory cytokine production in response to lipopolysaccharide (LPS) binding to Toll-like receptor 4 (TLR4) [28]. This evidence concerns the gene TLR4 and cervical carcinoma.